Summary:
A research study comparing an Injection of Toujeo versus Lantus in Patients With Type 1 Diabetes Mellitus. There are a total of 20 study visits (8 on site visits and 12 telephone visits).
Qualified Participants Must:
• Be diagnosed with Type 1 Diabetes
•
Have at least one year of stable dose treatment of basal plus mealtime insulin
Qualified Participants May Receive:
$50 compensation for time and travel for each visit; study-related procedures at no cost.